Prime Capital Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Sell |
639
-456
| -42% | -$240K | ﹤0.01% | 733 |
|
|
2025
Q1 | $695K | Buy |
1,095
+596
| +119% | +$378K | 0.01% | 578 |
|
|
2024
Q4 | $355K | Sell |
499
-799
| -62% | -$569K | 0.01% | 664 |
|
|
2024
Q3 | $1.36M | Buy |
1,298
+19
| +1% | +$20K | 0.02% | 377 |
|
|
2024
Q2 | $1.34M | Sell |
1,279
-181
| -12% | -$190K | 0.02% | 380 |
|
|
2024
Q1 | $1.41M | Buy |
1,460
+609
| +72% | +$586K | 0.02% | 404 |
|
|
2023
Q4 | $747K | Buy |
851
+223
| +36% | +$196K | 0.01% | 483 |
|
|
2023
Q3 | $517K | Buy |
628
+98
| +18% | +$80.7K | 0.01% | 466 |
|
|
2023
Q2 | $381K | Buy |
+530
| New | +$381K | 0.01% | 537 |
|
|
2021
Q2 | – | Sell |
-5
| Closed | -$2K | – | 505 |
|
|
2021
Q1 | $2K | Buy |
+5
| New | +$2K | ﹤0.01% | 448 |
|